[Changes in immune and fibrinolytic systems of patients with atherosclerosis and chronic nonspecific pulmonary diseases].
The study of immune and fibrinolytic systems in 216 atherosclerosis patients with associated chronic obstructions of the lungs revealed a discrete pattern of activity of plasminogen activator which is low in atherosclerosis in contrast to its elevation in combination of atherosclerosis with pulmonary obstructions. The latter cases manifest E-RFC relative number to be reduced in increased number of EAC-RFC. Growing amount of EA-RFM, elevated blood antithrombin III, activation of plasminogen activator in atherosclerosis coexistence with obstructive pulmonary lesions arrest the development of latent DIC syndrome and progression of atherosclerosis.
Kamenev
V F
VF
D001161:Arteriosclerosis / Q000097:blood* / Q000150:complications / Q000276:immunology*; D001780:Blood Coagulation Tests; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007958:Leukocyte Count; D008173:Lung Diseases, Obstructive / Q000150:complications*; D008214:Lymphocytes / Q000276:immunology; D012397:Rosette Formation
D007136:Immunoglobulins
Izmeneniia immunnoĭ i fibrinoliticheskoĭ sistemy u bol'nykh aterosklerozom pri khronicheskikh nespetsificheskikh zabolevaniiakh legkikh.